Feature Channels: Autoimmune Diseases

Filters close
Released: 16-Jun-2021 1:10 PM EDT
Mayo Clinic Laboratories offers first test to detect recently discovered autoimmune disease associated with testicular cancer
Mayo Clinic

Mayo Clinic Laboratories has launched a first-of-its-kind autoimmune test for the Kelch-like protein 11 antibody, or KLHL11, which is used to detect autoimmune disease associated with testicular cancer. The test is available nationally and internationally.

Released: 9-Jun-2021 3:05 PM EDT
AARDA Announces Six New Board Members
American Autoimmune Related Diseases Association (AARDA)

The American Autoimmune Related Diseases Association (AARDA) announced six new board members and two new advisors to the board. Each will help support AARDA’S mission of improving the lives affected by autoimmune disease, through awareness, education, advocacy, and research.

Released: 3-Jun-2021 12:00 PM EDT
Researchers discover potential new approach to treating psoriatic joint inflammation
UC Davis Health

An international team of researchers, led by UC Davis Health, developed a new therapeutic approach to treating psoriatic arthritis, a chronic inflammatory disease affecting the joints.

Newswise: Top Researchers Identify Areas for Autoimmune Disease Research at AARDA-Hosted Colloquium
Released: 2-Jun-2021 11:25 AM EDT
Top Researchers Identify Areas for Autoimmune Disease Research at AARDA-Hosted Colloquium
American Autoimmune Related Diseases Association (AARDA)

The American Autoimmune Related Disease Association (AARDA) hosted the 15th Noel Rose Scientific Colloquium on May 1, 2021, bringing together high-level researchers from different areas and specialties.

Newswise:Video Embedded new-research-optimizes-body-s-own-immune-system-to-fight-cancer
VIDEO
Released: 14-May-2021 11:40 AM EDT
New research optimizes body’s own immune system to fight cancer
University of Minnesota College of Science and Engineering

A groundbreaking study led by engineering and medical researchers at the University of Minnesota Twin Cities shows how engineered immune cells used in new cancer therapies can overcome physical barriers to allow a patient’s own immune system to fight tumors. The research could improve cancer therapies in the future for millions of people worldwide.

Newswise: Researchers Develop First-in-Class Inhibitors Against Key Leukemia Protein
Released: 14-May-2021 8:05 AM EDT
Researchers Develop First-in-Class Inhibitors Against Key Leukemia Protein
Michigan Medicine - University of Michigan

Researchers have developed first-in-class small-molecule inhibitors against a key leukemia protein, ASH1L.

Released: 12-May-2021 11:20 AM EDT
Ancient gut microbiomes may offer clues to modern diseases
Joslin Diabetes Center

Scientists are rapidly gathering evidence that variants of gut microbiomes, the collections of bacteria and other microbes in our digestive systems, may play harmful roles in diabetes and other diseases.

Newswise: Research News Tip Sheet: Story Ideas from Johns Hopkins Medicine
Released: 12-May-2021 11:15 AM EDT
Research News Tip Sheet: Story Ideas from Johns Hopkins Medicine
Johns Hopkins Medicine

During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every other Wednesday.

Released: 10-May-2021 9:30 AM EDT
Patient support programs for painful conditions may reduce opioid use
Michigan Medicine - University of Michigan

Programs that provide ongoing support to patients with painful conditions and complex medication regimens may also help them avoid using potentially risky opioid pain medications, or reduce the amount they use, a new study finds.

Released: 26-Apr-2021 9:00 AM EDT
Anemia Discovery Points to More Effective Treatment Approaches
University of Virginia Health System

A combination of inexpensive oral medications may be able to treat fatigue-inducing anemias caused by chronic diseases and inflammation, a new discovery from the University of Virginia School of Medicine suggests.

Newswise: Researchers Discover Common Mechanism Causing Autoimmune Disease and Blood Cancers
19-Apr-2021 8:00 AM EDT
Researchers Discover Common Mechanism Causing Autoimmune Disease and Blood Cancers
Yale Cancer Center

In a study by Yale Cancer Center, researchers report on the discovery of a common mechanism that promotes both autoimmune diseases and blood cancers, including the blood diseases Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL).

Released: 31-Mar-2021 9:30 AM EDT
Repurposing Tocilizumab in Scleroderma Patients May Prevent Early Lung Disease
Michigan Medicine - University of Michigan

A phase 3 clinical trial finds an anti-inflammatory drug used in rheumatoid arthritis can preserve lung function in patients with systemic sclerosis.

Released: 26-Mar-2021 10:40 AM EDT
Research Group Identifies Potential Therapeutic Target for Lupus
Michigan Medicine - University of Michigan

Inhibiting IRE1α, a molecule activated by the endoplasmic reticulum in neutrophils, counters disease progression in lupus mice.

Released: 19-Mar-2021 9:45 AM EDT
Cancer Immunotherapy May Also Treat Certain Autoimmune Diseases
Michigan Medicine - University of Michigan

The new approach blocks the interaction between cancer cells and immune receptors, showing promise in mice.

Released: 9-Mar-2021 2:05 PM EST
Corrona Announces Name Change to CorEvitas and Expanded Strategic Direction
Corrona, LLC

Corrona, LLC, a leading provider of real-world evidence solutions, announced today that it has changed its name to CorEvitas [kohr-eh'-vi-tahs].

Newswise: LJI research leads to promising combination therapy for type 1 diabetes
Released: 9-Mar-2021 11:40 AM EST
LJI research leads to promising combination therapy for type 1 diabetes
La Jolla Institute for Immunology

Translational research led by scientists at La Jolla Institute for Immunology (LJI) has resulted in a promising combination therapeutic candidate for adults with recent-onset type 1 diabetes.

Newswise:Video Embedded video-should-i-get-the-covid-19-if-i-have-an-autoimmune-disease
VIDEO
Released: 9-Mar-2021 11:20 AM EST
"Video: Should I get the COVID-19 if I have an autoimmune disease?"
American Autoimmune Related Diseases Association (AARDA)

The approval of COVID-19 vaccines has brought with it hope, excitement, as well as concerns. AARDA is committed to ensuring you have the information you need to make the right decisions for your health. A panel of medical experts will discuss frequently asked questions regarding COVID-19 vaccines, as well as address audience questions.

Newswise: March Special Issue of The American Journal of Gastroenterology Focuses on Women’s Health in Gastroenterology and Hepatology
Released: 9-Mar-2021 8:00 AM EST
March Special Issue of The American Journal of Gastroenterology Focuses on Women’s Health in Gastroenterology and Hepatology
American College of Gastroenterology (ACG)

The March issue of The American Journal of Gastroenterology features new clinical research involving sex and gender, including effects of GI and liver conditions on pregnancy, gender disparities in diet and nutrition, Barrett’s esophagus incidence in women with scleroderma, factors influencing whether women pursue advanced endoscopy careers, endoscopy-related musculoskeletal injuries, sex hormone association with increased prevalence of certain types of cancer, and more.

1-Mar-2021 9:40 AM EST
Study Reveals Details of Immune Defense Guidance System
NYU Langone Health

At the beginning of an immune response, a molecule known to mobilize immune cells into the bloodstream, where they home in on infection sites, rapidly shifts position, a new study shows. Researchers say this indirectly amplifies the attack on foreign microbes or the body’s own tissues.

Newswise: Harnessing the Power of Proteins in our Cells to Combat Disease
Released: 25-Feb-2021 12:10 PM EST
Harnessing the Power of Proteins in our Cells to Combat Disease
University of Nevada, Las Vegas (UNLV)

A lab on UNLV’s campus has been a hub of activity in recent years, playing a significant role in a new realm of drug discovery — one that could potentially provide a solution for patients who have run out of options.

Newswise: Distinguishing Between Two Very Similar Pediatric Brain Conditions
Released: 23-Feb-2021 12:00 PM EST
Distinguishing Between Two Very Similar Pediatric Brain Conditions
UT Southwestern Medical Center

Slight differences in clinical features can help physicians distinguish between two rare but similar forms of autoimmune brain inflammation in children, a new study by UT Southwestern scientists suggests. The findings, published online in Pediatric Neurology, could provide patients and their families with a better prognosis and the potential to target treatments specific to each condition in the future.

Released: 22-Feb-2021 12:30 PM EST
Expert Alert: Encephalitis prevention another reason to receive COVID-19 vaccine
Mayo Clinic

Patients with COVID-19 are at risk for neurologic complications, including encephalitis, or inflammation of the brain. "Encephalitis cases have been reported in patients with COVID-19, although on the whole it appears to be a relatively rare complication," says Michel Toledano, M.D., a Mayo Clinic neurologist. In the case of encephalitis caused by communicable diseases for which there is a vaccine available, getting vaccinated is the best way of preventing the disease.

Newswise: Autoimmune Newscast: Should I Get the COVID-19 Vaccine?
Released: 19-Feb-2021 3:35 PM EST
Autoimmune Newscast: Should I Get the COVID-19 Vaccine?
American Autoimmune Related Diseases Association (AARDA)

The approval of COVID-19 vaccines has brought with it hope, excitement, as well as concerns. AARDA is committed to ensuring you have the information you need to make the right decisions for your health. A panel of medical experts will discuss frequently asked questions regarding COVID-19 vaccines, as well as address audience questions during our upcoming Autoimmune Newscast, “Should I Get the COVID-19 Vaccine?” on 2/26 at 2pm ET

15-Feb-2021 9:50 AM EST
Medication Keeps More Patients with ANCA-Associated Vasculitis in Remission Than Steroids
Perelman School of Medicine at the University of Pennsylvania

Avacopan, which targets a receptor that attracts the cells that cause inflammation, was shown to be more effective at keeping patients in remission for a year than prednisone

Newswise:/images/icons/audio_thumb_100x75.png
AUDIO
Released: 11-Feb-2021 5:15 PM EST
ACR COVID-19 Vaccine Guidance Recommends Vaccination, Addresses Immunosuppressant Drugs & Patient Concerns
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) has released its COVID-19 Vaccine Clinical Guidance Summary that provides an official recommendation to vaccinate rheumatology patients with musculoskeletal, inflammatory and autoimmune diseases. Important considerations and caveats on how to approach vaccination are included for patients with high disease activity and/or those taking immunosuppressant treatments.

Released: 2-Feb-2021 7:00 AM EST
Surgery to Heal Inflamed Gut May Create New Target for Disease
NYU Langone Health

A surgical procedure meant to counter ulcerative colitis, an immune disease affecting the colon, may trigger a second immune system attack, a new study shows.

Released: 28-Jan-2021 1:10 PM EST
Scientists Find Key Function of Molecule in Cells Crucial for Regulating Immunity
University of North Carolina School of Medicine

Scientists discovered that the molecule AIM2 is important for the proper function of regulatory T cells and plays a key role in mitigating autoimmune disease. Treg cells are a seminal population of adaptive immune cells that prevents an overzealous immune responses.

Released: 22-Jan-2021 10:20 AM EST
Cross-Country Research Collaboration Brings First Ever Lupus Estimates
Michigan Medicine - University of Michigan

A meta-analysis of lupus finds the disease is less common than previously thought, but disproportionally affects women and racial and ethnic minorities of both sexes.

18-Jan-2021 9:00 AM EST
Study Pins Down Number of Americans with Most Common Form of Lupus
NYU Langone Health

Just over 200,000 Americans suffer from systemic lupus erythematosus, or SLE, a condition in which the body's immune system mistakenly attacks its own healthy tissues, especially joints and skin, a new study shows.

Released: 19-Jan-2021 11:35 AM EST
National Research Effort Discovers Relationship Between Inflammation, Metabolism and Scleroderma Scarring
Michigan Medicine - University of Michigan

Study finds NAD+ break down leads to multi organ scarring, providing now a previously undiscovered pathogenic role of the enzyme CD38 in disease scarring.

Released: 13-Jan-2021 12:30 PM EST
AARDA Announces Leadership Transition
American Autoimmune Related Diseases Association (AARDA)

The American Autoimmune Related Diseases Association announced that Randall Rutta, President and CEO, is leaving to join the National Health Council (NHC) as its CEO, effective February 12, 2021.

Released: 6-Jan-2021 11:05 AM EST
New Research Finds Ginger Counters Certain Autoimmune Diseases in Mice
Michigan Medicine - University of Michigan

The main bioactive compound of ginger root lowers autoantibody production and helps halt disease progression in mice with antiphospholipid syndrome and lupus.

Released: 17-Dec-2020 3:15 PM EST
Protein Linked to Progressive Lung Scarring in Scleroderma Patients
Michigan Medicine - University of Michigan

Osteopontin is discovered as the culprit behind these patients’ main cause of death. However, a repurposed immunosuppressive drug may combat the pro-inflammatory protein.

Newswise: Targeting T cell protein could prevent type 1 diabetes, study suggests
2-Dec-2020 9:50 AM EST
Targeting T cell protein could prevent type 1 diabetes, study suggests
The Rockefeller University Press

Researchers at the University of Utah School of Medicine have identified a new therapeutic target to treat patients with type 1 diabetes. The study, which will be published December 9 in the Journal of Experimental Medicine (JEM), reveals that inhibiting a protein called OCA-B protects mice from type 1 diabetes by limiting the activity of immune cells that would otherwise destroy the pancreas’ insulin-producing β cells.

Released: 17-Nov-2020 9:55 AM EST
Study explores sleep apnea, autoimmune disease link
University of Georgia

New research by University of Georgia scientists sheds light on why people with obstructive sleep apnea may have associated autoimmune disorders. The results could lead to better approaches to treatment and possibly new drug therapies.

8-Nov-2020 9:00 AM EST
Improving the Diagnosis of Chronic Nonbacterial Osteomyelitis, an Underdiagnosed Chronic Autoinflammatory Syndrome
Hospital for Special Surgery

Researchers have identified several factors that should help improve the diagnosis of chronic nonbacterial osteomyelitis (CNO), also known as chronic recurrent multifocal osteomyelitis (CRMO). The new study was presented at the virtual annual meeting of the American College of Rheumatology.

Released: 6-Nov-2020 9:00 AM EST
With Close Monitoring Throughout, Safe Pregnancy is Possible for Women with Interstitial Lung Disease
American College of Rheumatology (ACR)

A new study shows that women with interstitial lung disease (ILD) related to autoimmune disease may not need to terminate their pregnancies provided they have close monitoring from their team of multidisciplinary physicians before, during and after pregnancy. Results of the research was presented at ACR Convergence, the American College of Rheumatology’s annual meeting.

Released: 6-Nov-2020 9:00 AM EST
Many with Lupus at High Risk for Adverse Reactions to Pneumocystis Pneumonia Preventive Drug
American College of Rheumatology (ACR)

New research shows that adults with systemic lupus erythematosus, who receive trimethoprim-sulfamethoxazole (TMP-SMX) are at high risk for adverse reactions to the drug, particularly if they are also positive for anti-Smith (anti-Sm) antibodies. Details of the study was presented at ACR Convergence, the American College of Rheumatology’s annual meeting.

Released: 6-Nov-2020 9:00 AM EST
Hydroxychloroquine Not Linked to Longer Heart Rhythm Intervals in Rheumatoid Arthritis or Lupus Patients
American College of Rheumatology (ACR)

New research presented at ACR Convergence, the American College of Rheumatology’s annual meeting, discovers that use of hydroxychloroquine does not cause any significant differences in QTc length or prolonged QTc in people with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE).

2-Nov-2020 12:25 PM EST
A Novel Immunotherapy Proves Effective in Animal Models of Multiple Sclerosis
Thomas Jefferson University

Jefferson researchers develop an approach to specifically impede the autoimmune response that drives the disease, while leaving the rest of the immune system fully functioning.

21-Oct-2020 3:35 PM EDT
New Population of Immune Cells Could Play a Role in Multiple Sclerosis
Thomas Jefferson University

Researchers uncover defining features of a subset of T-cells that may drive autoimmunity in MS, and could prove to be a new target for therapy.


Showing results

150 of 986

close
2.39875